drugs

Novartis to dock new panel firms’ fees if they miss diversity commitments

Allen & Overy, Simpson Thacher & Bartlett and White & Case are among the firms that have lost their spots on the panel of Swiss pharmaceutical powerhouse Novartis, which has formally concluded its review. Other firms were dropped from the chunky line-up, which includes no fewer than 22 firms. Others that will no longer be […]

Freeths restructures management as CEO retires after 20 years

National firm Freeths has restructured its management team, with its leader of 20 years retiring. CEO Peter Smith had led the firm since 2000, overseeing a period which saw it transform from Freeth Cartwright, a relatively small East Midlands player, into Freeths, a national firm which overtook the likes of DLA Piper in terms of […]